Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 07, 2020 1:00 PM - Oct 09, 2020 6:30 PM

(W. Europe Standard Time)

4051 Basel, Switzerland

Future of Evidence and Smart Health Conference

Session 6: Block Chain

Session Chair(s)

Adama  Ibrahim, MBA

Adama Ibrahim, MBA

Vice President, Digital Strategy and Change Management

Novo Nordisk, United Kingdom

Blockchain technology increases security and speeds up the exchange of information in a way that is cost-effective and more transparent. This technology has been increasingly used and considered in the healthcare sector as it can be applied to several aspects of the drug discovery and development lifecycle, namely data management, clinical trials, supply chain compliance, among many others. At this session, you will hear key stakeholders and users of Blockchain in Drug Development discussing challenges, risks and benefits.

Speaker(s)

Representative Invited

Regulator View

Representative Invited

FDA

Jeanne   Barnett

The Patient Advocate Perspective

Jeanne Barnett

CysticFibrosis.com, United States

Pathfinder for Patients and Caregivers, Teacher, CEO/Founder

Heather  Flannery

Heather Flannery

Equideum Health, United States

Founder and Chief Executive Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.